- cafead   Jul 18, 2023 at 10:22: PM
via After bagging a highly anticipated FDA nod Monday, Sanofi and AstraZeneca’s respiratory syncytial virus (RSV) antibody now has a date on a committee's calendar to determine its place in U.S. immunization guidelines.
article source
article source